Total Payments
$858.50
2024 Payments
$270.03
Companies
10
Transactions
19
Medicare Patients
4,842
Medicare Billing
$312,714
Payment Breakdown by Category
Food & Beverage$831.50 (96.9%)
Education$27.00 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $831.50 | 17 | 96.9% |
| Education | $27.00 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $293.63 | 4 | $0 (2023) |
| Galderma Laboratories, L.P. | $151.38 | 4 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $114.55 | 2 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $102.72 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51.30 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $48.37 | 1 | $0 (2024) |
| LEO Pharma Inc. | $35.43 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $30.03 | 2 | $0 (2024) |
| Lilly USA, LLC | $17.69 | 1 | $0 (2024) |
| GENZYME CORPORATION | $13.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $270.03 | 8 | Novartis Pharmaceuticals Corporation ($73.81) |
| 2023 | $198.87 | 3 | PFIZER INC. ($156.75) |
| 2022 | $45.96 | 1 | PFIZER INC. ($45.96) |
| 2021 | $52.95 | 1 | Galderma Laboratories, L.P. ($52.95) |
| 2018 | $263.69 | 4 | PFIZER INC. ($90.92) |
| 2017 | $27.00 | 2 | Galderma Laboratories, L.P. ($27.00) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $51.30 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $48.37 | General |
| Category: Immunology | ||||||
| 02/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $73.81 | General |
| Category: Dermatology | ||||||
| 02/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $35.43 | General |
| Category: DERMATOLOGY | ||||||
| 10/19/2023 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $81.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $75.72 | General |
| Category: Inflammation & Immunology | ||||||
| 10/19/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | TARGRETIN (Drug) | Food and Beverage | In-kind items and services | $42.12 | General |
| Category: Oncology | ||||||
| 10/22/2022 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $45.96 | General |
| 10/21/2021 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $52.95 | General |
| Category: ACNE | ||||||
| 10/20/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $90.92 | General |
| Category: DERMATOLOGY | ||||||
| 10/20/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $40.74 | General |
| Category: DERMATOLOGY | ||||||
| 10/19/2018 | Galderma Laboratories, L.P. | SOOLANTRA (Drug) | Food and Beverage | In-kind items and services | $71.43 | General |
| Category: ROSACEA | ||||||
| 10/18/2018 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $60.60 | General |
| Category: DERMATOLOGY | ||||||
| 08/08/2017 | Galderma Laboratories, L.P. | EPIDUO FORTE (Drug) | Education | In-kind items and services | $13.50 | General |
| Category: ACNE | ||||||
| 05/09/2017 | Galderma Laboratories, L.P. | EPIDUO FORTE (Drug) | Education | In-kind items and services | $13.50 | General |
| Category: ACNE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,166 | 1,972 | $590,950 | $73,154 |
| 2022 | 15 | 1,285 | 2,319 | $635,341 | $84,400 |
| 2021 | 16 | 1,285 | 2,179 | $601,894 | $87,178 |
| 2020 | 18 | 1,106 | 1,871 | $480,970 | $67,983 |
Total Patients
4,842
Total Services
8,341
Medicare Billing
$312,714
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 302 | 394 | $129,219 | $20,806 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 180 | $87,360 | $13,413 | 15.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 120 | 143 | $72,705 | $9,072 | 12.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 175 | 215 | $94,894 | $7,741 | 8.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 31 | $27,938 | $3,415 | 12.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 45 | 52 | $28,997 | $3,292 | 11.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 64 | 82 | $18,860 | $2,920 | 15.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 131 | 658 | $52,528 | $2,834 | 5.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $18,033 | $2,416 | 13.4% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 15 | 15 | $16,430 | $2,244 | 13.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 14 | 15 | $14,330 | $1,548 | 10.8% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $12,201 | $1,457 | 11.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 12 | 12 | $5,520 | $805.14 | 14.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 22 | $6,820 | $706.86 | 10.4% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 11 | 11 | $4,527 | $439.36 | 9.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 84 | $588.00 | $43.12 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 299 | 407 | $127,391 | $22,036 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 249 | $115,785 | $20,101 | 17.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 219 | 300 | $127,500 | $11,410 | 8.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 125 | 144 | $69,840 | $9,658 | 13.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 82 | 106 | $23,320 | $3,952 | 16.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 166 | 865 | $69,200 | $3,768 | 5.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 38 | 44 | $23,320 | $3,489 | 15.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 19 | 22 | $18,810 | $2,294 | 12.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $19,780 | $2,102 | 10.6% |
About Dr. Laura Van Why, MD
Dr. Laura Van Why, MD is a Dermatology healthcare provider based in Fond Du Lac, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932132107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Van Why, MD has received a total of $858.50 in payments from pharmaceutical and medical device companies, with $270.03 received in 2024. These payments were reported across 19 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($831.50).
As a Medicare-enrolled provider, Van Why has provided services to 4,842 Medicare beneficiaries, totaling 8,341 services with total Medicare billing of $312,714. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Fond Du Lac, WI
- Active Since 07/09/2006
- Last Updated 11/28/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1932132107
Products in Payments
- EUCRISA (Drug) $90.92
- LITFULO (Drug) $81.03
- CIBINQO (Drug) $75.72
- COSENTYX (Drug) $73.81
- SOOLANTRA (Drug) $71.43
- SILIQ (Drug) $60.60
- AKLIEF (Drug) $52.95
- SPEVIGO (Drug) $51.30
- Sotyktu (Drug) $48.37
- DUPIXENT (Biological) $43.43
- TARGRETIN (Drug) $42.12
- COSENTYX (Biological) $40.74
- ADBRY (Biological) $35.43
- EPIDUO FORTE (Drug) $27.00
- TALTZ (Drug) $17.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.